MoonLake Immunotherapeutics (MLTX)
51.86
+2.04
(+4.09%)
USD |
NASDAQ |
Nov 21, 16:00
52.02
+0.16
(+0.30%)
After-Hours: 20:00
MoonLake Immunotherapeutics Total Assets (Quarterly): 518.21M for Sept. 30, 2024
Total Assets (Quarterly) Chart
Historical Total Assets (Quarterly) Data
| Date | Value |
|---|---|
| September 30, 2024 | 518.21M |
| June 30, 2024 | 544.88M |
| March 31, 2024 | 564.12M |
| December 31, 2023 | 526.54M |
| September 30, 2023 | 500.22M |
| June 30, 2023 | 506.62M |
| Date | Value |
|---|---|
| March 31, 2023 | 66.80M |
| December 31, 2022 | 76.84M |
| September 30, 2022 | 88.59M |
| June 30, 2022 | 98.43M |
| December 31, 2021 | 9.682M |
Total Assets Definition
Assets are a main portion of the balance sheet of a company that measure things that provide economic value. A few examples of assets of a company include cash, inventories, and accounts receivable. From an accounting perspective, the balance sheet equation is Assets = Liabilities + Shareholder's Equity.
Total Assets (Quarterly) Range, Past 5 Years
9.682M
Minimum
Dec 2021
564.12M
Maximum
Mar 2024
318.27M
Average
500.22M
Median
Sep 2023
Total Assets (Quarterly) Benchmarks
| Novartis AG | 103.52B |
| AC Immune SA | 290.33M |
| CRISPR Therapeutics AG | 2.256B |
| Addex Therapeutics Ltd | 15.24M |
| NLS Pharmaceutics Ltd | 1.194M |
Total Assets (Quarterly) Related Metrics
| Total Liabilities (Quarterly) | 22.71M |
| Shareholders Equity (Quarterly) | 488.20M |